Yu, E., & Bell, D. W. The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-β signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationYu, Eun-Jeong, and Daphne W. Bell. The Endometrial Cancer A230V-ALK5 (TGFBR1) Mutant Attenuates TGF-β Signaling and Exhibits Reduced in Vitro Sensitivity to ALK5 Inhibitors. Public Library of Science (PLoS).
MLA (9th ed.) CitationYu, Eun-Jeong, and Daphne W. Bell. The Endometrial Cancer A230V-ALK5 (TGFBR1) Mutant Attenuates TGF-β Signaling and Exhibits Reduced in Vitro Sensitivity to ALK5 Inhibitors. Public Library of Science (PLoS).
Warning: These citations may not always be 100% accurate.